COMMUNICATION
News & Press Release
Total 122
-
122[파이낸셜 리뷰] 뉴로바이오젠, ‘KDS2010 글로벌 롱제비티 비전 및 파트너십 포럼’ 개최
DATE : 2025-06-04
VIEW : 1881
-
121[경향신문] 뉴로바이오젠, 미국 제약사 사이렉스 바이오와 글로벌 라이선스 계약 맺어
DATE : 2025-06-04
VIEW : 1989
-
120Scilex Holding Company Announces 1-for-35 Reverse Stock Split
DATE : 2025-04-14
VIEW : 1856
-
119Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Pref
DATE : 2025-03-26
VIEW : 1916
-
118[BioRxiv]Astrocytic MAOB-GABA axis as a molecular brake on repair following spinal cord injury
DATE : 2025-02-27
VIEW : 1890
-
117Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Pref
DATE : 2025-01-07
VIEW : 2051
-
116Scilex Holding Company Announces Early Installment Payment on its Senior Secured Promissory Note, Pa
DATE : 2024-12-17
VIEW : 2189
-
115Scilex Bio, a Controlling Interest of Joint Venture by Scilex Holding Company, Reports KDS2010 a Nov
DATE : 2024-12-16
VIEW : 3565
-
114Scilex Bio, a Controlling Interest of Joint Venture by Scilex Holding Company, Reports Phase 2 Trial
DATE : 2024-12-16
VIEW : 2156
-
113Scilex Holding Company Enters into a Binding Term Sheet for a Joint Venture with IPMC and Bio Open I
DATE : 2024-12-16
VIEW : 2438
- Add(06714) 2 FL, Bangbae BLDG, 9, Myeongdal-ro, Seocho-gu, Seoul, Republic of Korea
- Tel+82-70-4018-8009
- Fax+82-02-3486-2613
- E-mailneuro_reply@neurobiogen.com
FAMILY SITE
COPYRIGHT ⓒ 2025 NEUROBIOGEN. All rights reserved